Showing results (121-130 of 463) with videos related to
Sort By:
Pageof 47
Lancet (London, England)|June 20, 2003
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trialsDeepak P Vivekananthan, Marc S Penn, Shelly K Sapp, et al.Health Communication|February 7, 2013
Characteristics of genomic test consumers who spontaneously share results with their health care providerBurcu F Darst, Lisa Madlensky, Nicholas J Schork, et al.Journal of Lipid Research|February 5, 2008
Identification of a novel locus for triglyceride on chromosome 1p31-32 in families with premature CAD and MISara Bretschger Seidelmann, Lin Li, Gong-Qing Shen, et al.Journal of the American College of Cardiology|March 26, 2003
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseasePatricia A Gum, Kandice Kottke-Marchant, Patricia A Welsh, et al.Personalized Medicine|June 23, 2011
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?Elizabeth O Lillie, Bradley Patay, Joel Diamant, et al.The Journal of Invasive Cardiology|July 11, 2007
Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trialSorin J Brener, Steven R Steinhubl, Peter B Berger, et al.American Heart Journal|February 3, 2009
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trialHerbert D Aronow, Steven R Steinhubl, Danielle M Brennan, et al.Journal of the American College of Cardiology|December 12, 2002
Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortalitySorin J Brener, Bruce W Lytle, Jakob P Schneider, et al.Journal of the American College of Cardiology|March 19, 2004
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplastyJohn A Bittl, Derek P Chew, Eric J Topol, et al.European Heart Journal|January 13, 2009
Patients with peripheral arterial disease in the CHARISMA trialPatrice P Cacoub, Deepak L Bhatt, P Gabriel Steg, et al.Pageof 47